Insider activity reported on Tuesday contains a mix of confidence-driven purchases in smaller-cap and distressed securities and planned disposals by long-standing holders at larger companies. The filings detail both direct and indirect acquisitions by ten percent owners and limited partnership vehicles, and multiple sales executed under Rule 10b5-1 trading plans. Below is a company-by-company account of the most notable buys and sells disclosed.
Top purchases reported
Palmer Square Capital BDC Inc. - A large indirect acquisition was disclosed by Martin C Bicknell, identified as a ten percent owner. According to filings, Mr. Bicknell purchased common stock with an aggregate value of approximately $647,337 through transactions executed on July 6 and July 7, 2026. On July 6 specifically, he acquired 40,000 shares of common stock at a weighted average price of $10.56 per share. Those shares were bought in multiple trades at prices that ranged from $10.50 to $10.69 and were held indirectly via MCHC, LLC.
CapsoVision, Inc. - Ten percent owner Eliyahou Harari increased his indirect holding on June 26, 2026 with a purchase of common stock valued at $101,811. The filing records the acquisition of 13,850 shares at a price of $7.351 per share. After the transaction, Mr. Harari’s indirect holdings in CapsoVision common stock stand at 3,200,751 shares, held by the Harari Family Trust, for which he and his wife act as trustees. The filing notes the market price has moved against the purchase: CapsoVision shares are trading at $5.67, approximately 23% below Mr. Harari’s purchase price. Additional commentary in the filing references a recent sharp decline - shares down over 23% in the last week - and cites an analysis that places the stock as overvalued relative to its Fair Value and listed among considerations for a Most Overvalued list.
Edible Garden AG Inc. - HRT Financial LP, reported as a ten percent owner, added shares through several transactions in early July. Across three trades between July 1 and July 6, 2026, HRT Financial LP bought a total of 416,812 shares of Edible Garden AG common stock, with prices per share ranging from $0.119 to $0.166. The cumulative value of these purchases was $63,435. At the time of the filing, EDBL stock was trading at $0.09, close to its 52-week low of $0.10, after a steep 39% decline over the prior week. The filing references an analysis that suggests the stock appears undervalued with a Fair Value of $0.13 and that it could be listed among the most undervalued stocks.
Total Return Securities Fund - The fund’s President and CEO, Andrew Dakos, disclosed an indirect purchase on July 2, 2026 totaling $29,601. The transaction consisted of 5,000 shares of common stock bought at prices ranging from $5.92 to $5.9203 per share. Those shares are held indirectly through a limited partnership in which Mr. Dakos has a beneficial interest, although he disclaims beneficial interest except to the extent of any pecuniary interest. Following the purchase, Mr. Dakos indirectly holds 131,000 shares and directly owns an additional 40,000 shares of the fund’s common stock. The filing highlights the timing of the purchase, noting the stock trades at $5.98, near a 52-week low of $5.84. Financial metrics cited in the filing show the fund produced earnings per share of $1.06 over the last twelve months and currently trades at a P/E ratio of 5.66.
Wheeler Real Estate Investment Trust, Inc. - HRT Financial LP also reported purchases of Wheeler Real Estate Investment Trust common stock, totaling $25,880. The Form 4 details a July 2, 2026 purchase of 17,348 shares at $1.39 per share, lifting HRT Financial LP’s direct holdings to 99,680 shares. The filing additionally notes prior purchases occurred at prices ranging from $0.0814 to $1.39 per share. At the time of disclosure, the REIT’s shares were trading at $0.56, a 41% decline over the previous week and nearly a 99% decline year-to-date. The filing cites analysis indicating the relative strength index (RSI) places WHLR in oversold territory, identified as one of twelve ProTips available to subscribers of the analysis service referenced.
Top sales reported
Arista Networks - Andreas Bechtolsheim, listed as a 10% owner, sold 230,900 shares of the company’s common stock on July 2, 2026. The reported proceeds from those transactions amount to approximately $39,040,875, with trade prices ranging between $157.242 and $167.0659 per share. The sales were carried out under a Rule 10b5-1 trading plan that Mr. Bechtolsheim put in place on February 20, 2026. All shares in these transactions were held indirectly by a family trust for which Mr. Bechtolsheim serves as trustee. The filing places the sale in the context of Arista’s market position, noting that the stock is trading at $166.35, close to its 52-week high of $179.80, and has gained 64% over the past year.
Palantir Technologies Inc. - Chief Technology Officer and Executive Vice President Sankar Shyam reported the sale of 185,000 shares of Class A Common Stock on July 2, 2026, with total proceeds of $24,050,000. All shares were sold at $130.0 each. These transactions were executed under a Rule 10b5-1 trading plan established on March 11, 2026. The filing specifies that 35,000 of the sold shares were acquired through the conversion of an equal number of Class B Common Stock shares into Class A Common Stock on a one-for-one basis; those Class B shares are described as convertible with no expiration date. The filing notes Palantir’s market price was $134.37 at the time of disclosure, and that shares are down 24% over the past six months. An analysis referenced in the filing indicates the stock appears overvalued relative to its Fair Value and has been listed among companies assessed as Most Overvalued.
Workday, Inc. - Significant shareholder David A. Duffield sold Class A Common Stock with an aggregate value of approximately $14.5 million on July 6, 2026. The transactions involved 107,500 shares sold at prices ranging from $129.23 to $139.2999 per share. The filing records that prior to these sales, Mr. Duffield converted 107,500 shares of Class B Common Stock into an equal number of Class A Common Stock, with Class B shares convertible to Class A shares at the holder’s option or automatically under certain conditions. These transactions were executed under a Rule 10b5-1 trading plan. The filing observes that Workday’s stock has since risen to $143.65, a 12.7% gain over the past week, but remains down 35% over the past six months. An analysis in the filing indicates Workday appears undervalued at current levels and notes the company’s market capitalization as $35.5 billion.
Adaptive Biotechnologies Corp - Chief Scientific Officer Harlan S Robins sold a total of 386,240 shares of common stock on July 2, 2026, with the transactions valued at approximately $8.5 million. The sales were carried out under a pre-arranged Rule 10b5-1 trading plan adopted on March 13, 2026. The filing details that the sales occurred in two transactions; the first transaction involved 239,351 shares sold at a weighted-average price of $21.74 per share, with executions occurring at prices ranging from $21.15 to $22.145.
Credit Acceptance Corp - Jill Foss Watson, identified as a 10% owner, sold 11,100 shares of common stock on July 2, 2026 for a total of $7,185,656. The sales were executed across multiple transactions at prices ranging from $646.77 to $666.22 per share. The filings contextualize the sale by noting the stock is trading near its 52-week high of $668.86 and has advanced 48% year-to-date. Analysis cited in the filing indicates the stock appears overvalued at current levels and that the RSI suggests the security is in overbought territory.
Context and interpretation
The batch of filings illustrates two clear patterns. First, several ten percent owners and investment vehicles have been buying shares of smaller or distressed names, often at or near 52-week lows, suggesting those shareholders view recent price levels as attractive entry points. Examples include the purchases in Edible Garden AG, Wheeler Real Estate Investment Trust, CapsoVision, and Palmer Square Capital BDC Inc. The filings for these purchases also include analytical notes that characterize some of the names as potentially undervalued or, in other cases, flagging near-term momentum weakness.
Second, larger dollar-value sales at established companies were largely executed under pre-arranged Rule 10b5-1 plans. Executives and substantial shareholders at Arista, Palantir, Workday, Adaptive Biotechnologies, and Credit Acceptance carried out planned dispositions. The filings emphasize that such sales were implemented via trading plans put in place months earlier and that some of the disposals involved shares converted from one class to another prior to sale.
Investors reading these filings should weigh the heterogeneous signals. Insider buying in low-priced, smaller-cap names may signal confidence from major holders, while sales under Rule 10b5-1 plans do not necessarily imply a negative view of company prospects; they often reflect pre-set liquidity management. The filings themselves point to additional indicators - such as proximity to 52-week highs and lows, year-to-date performance, valuation versus Fair Value, EPS and P/E metrics, and momentum indicators like RSI - which provide supplementary context to the disclosed trades.
Bottom line
The Tuesday filings show concentrated insider purchases in several smaller issues and material, planned sales by executives at larger firms. Each item of insider activity should be considered alongside the valuation and momentum indicators cited in the respective filings. While purchases can be read as expressions of confidence by significant shareholders, and sales sometimes reflect profit-taking or pre-arranged liquidity plans, neither category of transaction offers definitive guidance on future share performance without broader corroborating information.
Note on limitations: The disclosures reflect what insiders reported on their respective Form 4 filings and the accompanying analytical notes cited in those filings. Filings frequently describe holdings as direct or indirect and sometimes include conversion events; they may also reference third-party analysis. The filings do not explain the personal motives behind individual sales, and the presence of a Rule 10b5-1 plan indicates a pre-set trading schedule rather than ad hoc decisions.